Pharmaceuticals News and Research

RSS

China PharmaHub changes trading symbol to 'CPHB'

China PharmaHub Corp., which recently merged with World Wide Relics and, effective August 23, 2010, changed its name from World Wide Relics, Inc. to China PharmaHub Corp., announced today that effective Tuesday, September 7, 2010, its stock shall begin trading under the symbol "CPHB."

7 Sep 2010

Tikcro reports $3.2 million net loss for second-quarter 2010

Tikcro Technologies Ltd. today reported results for the second quarter and six months ended June 30, 2010.

7 Sep 2010

VirtualScopics enters molecular imaging collaboration with ABX-CRO

VirtualScopics, Inc., a leading provider of quantitative imaging for clinical trials, today announced it has entered into a scientific collaboration, specific to molecular imaging, with ABX-CRO, a Dresden, Germany based full-service contract research organization. The collaboration joins two of the scientific pioneers in the use of advanced imaging for the clinical study of drugs and medical devices.

7 Sep 2010

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

7 Sep 2010

FINRA approves Curaxis' change of trading symbol to 'CURX'

Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., announced today that the Financial Industry Regulatory Authority has approved the change of the company's trading symbol on the OTCBB market from ASCH to CURX effective immediately.

7 Sep 2010

Somaxon's Silenor now commercially available in U.S.

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that Silenor® (doxepin) now is commercially available by prescription in the United States. Somaxon has implemented a wholesale and retail stocking program to disseminate Silenor 3 mg and 6 mg dosepacks to pharmacies across the United States. Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

7 Sep 2010

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.

7 Sep 2010

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

At the 2010 World Molecular Imaging Congress in Kyoto, Bruker Corporation today announces the introduction of the Icon™, a new easy-to-use 1 Tesla desktop MRI scanner that combines simplicity with compact dimensions, in order to bring preclinical magnetic resonance imaging (MRI) within reach for a broader range of molecular imaging laboratories.

7 Sep 2010

Idenix Pharmaceuticals receives clinical hold order from FDA for IDX184, IDX320 programs

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company received verbal notice on Friday, September 3, 2010 from the U.S. Food and Drug Administration (FDA) that the IDX184 and IDX320 programs have been placed on clinical hold.

7 Sep 2010

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced today that it is expanding its pharmaceutical manufacturing capabilities for hot-melt extrusion.

7 Sep 2010

GI Dynamics announces data on EndoBarrier therapy for type 2 diabetes, obesity

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.

7 Sep 2010

Popularity of e cigarettes increase despite FDA's stance

Electronic cigarette sales and popularity continues to increase on a daily basis despite the US Food and Drug Administration's attempts to label the products as unsafe and untested for their intended purpose. Thousands of electronic cigarette reviews online dispute the stance of the FDA, many of them stating that the products have not only been tested, but by and large have been found to be less harmful than traditional cigarettes.

7 Sep 2010

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost manufacturing routes, DSM is offering focused and flexible stand alone route scouting services.

7 Sep 2010

Researchers discover new antibiotics in insect's brain

Cockroaches could be more of a health benefit than a health hazard according to scientists from the University of Nottingham, who have discovered powerful antibiotic properties in the brains of cockroaches and locusts.

7 Sep 2010

Scientists urge government to set target effectiveness for newly approved antibiotics

The United States must focus on conserving the use of antibacterial drugs, or face a public health crisis from rapidly rising rates of antibiotic-resistant infections, according to an analysis out today.

7 Sep 2010

Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.

6 Sep 2010

2010 Mainz University Meeting to focus Interdisciplinary Neurosciences

The 2010 Meeting of the Mainz University Research Focus on Interdisciplinary Neurosciences will be held on "Cognitive Enhancement Ethics and Society".

4 Sep 2010

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science, Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials, backed by Swiss pharmaceutical giant Novartis AG, could begin later this year," the Wall Street Journal writes (Naik, 9/3).

4 Sep 2010

Almost half of all Americans use prescription drugs each month

Nearly half of all Americans used at least one prescription drug per month in 2008, according to a study by the Centers for Disease Control and Prevention, Bloomberg reports. That's a 10 percent increase over the preceding decade. Over that time, yearly spending by Americans on drugs doubled to $234 billion. "The two biggest-sellers last year were Pfizer Inc.'s Lipitor for high cholesterol and Bristol-Myers Squibb Co.'s clot-buster, Plavix.

4 Sep 2010

Researchers reveal new details on bacterial cannibalism

Researchers at the University of California, San Diego have revealed new details about how cannibalistic bacteria identify peers suitable for consumption. The work, which employed imaging mass spectrometry, is a first step toward a broader effort to map all signaling molecules between organisms.

4 Sep 2010

Pharmaceuticals News and Research

China PharmaHub changes trading symbol to 'CPHB'

Tikcro reports $3.2 million net loss for second-quarter 2010

VirtualScopics enters molecular imaging collaboration with ABX-CRO

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

FINRA approves Curaxis' change of trading symbol to 'CURX'

Somaxon's Silenor now commercially available in U.S.

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

Idenix Pharmaceuticals receives clinical hold order from FDA for IDX184, IDX320 programs

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

GI Dynamics announces data on EndoBarrier therapy for type 2 diabetes, obesity

Popularity of e cigarettes increase despite FDA's stance

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

Researchers discover new antibiotics in insect's brain

Scientists urge government to set target effectiveness for newly approved antibiotics

Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA

2010 Mainz University Meeting to focus Interdisciplinary Neurosciences

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

Almost half of all Americans use prescription drugs each month

Researchers reveal new details on bacterial cannibalism

Event guide: World ADC San Diego eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence